Researchers have now developed a new antibiotic that is heralded as a breakthrough against a lethal drug-resistant hospital superbug. Antibiotic Ramizol was found safe and effective in addressing the Clostridium difficile (C. difficile) infection which is becoming resistant to traditional antibiotics caused by drug-resistant bacteria. C.difficile is considered one of the most common infections acquired during hospital visits and the most likely cause of diarrhoea for patients and staff in hospitals. It causes a deadly infection in the large intestine and is most common in people who need to take antibiotics for a long period of time. Cases of C.difficile
